Notably, other studies reported finding gain-of-function mutations of TYK2 in cells derived from a patient with CD30-positive lymphoproliferative disorders41 and T-cell acute lymphoblastic leukemia (T-ALL)-derived cell lines42. This evidence concerns the gene TYK2 and acute lymphoblastic leukemia.